Melanoma-associated antigens as messenger rna detection markers for melanoma

Cancer Research

Volumn 57, Issue 7, 1997, Pages 1371-1376

  Sarantou, Terry ^a   Chi, Dorcas D J ^b   Garrison, Darryl A ^b   Conrad, Andrew J ^b   Schmid, Peter ^b   Morton, Donald L ^a   Hoon, Dave S B ^a  

^a JOHN WAYNE CANCER INSTITUTE   (United States)

^b National Genetics Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MELANOMA ANTIGEN; MESSENGER RNA; TUMOR MARKER;

ANTIGEN DETECTION; ARTICLE; CANCER CYTODIAGNOSIS; CONTROLLED STUDY; HUMAN; HUMAN CELL; MELANOMA CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANTIGENS, NEOPLASM; BLOTTING, SOUTHERN; HUMANS; INTERFERON TYPE II; INTRAMOLECULAR OXIDOREDUCTASES; ISOMERASES; MELANOMA; MEMBRANE GLYCOPROTEINS; MONOPHENOL MONOOXYGENASE; NEOPLASM PROTEINS; POLYMERASE CHAIN REACTION; PROTEINS; RNA PROBES; RNA, MESSENGER; SKIN NEOPLASMS; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 0030955030     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Houghton, A. N. Cancer antigens: immune recognition of self and altered self. J. Exp. Med., 180: 1-4, 1994.
2. Fishman, P., Azizi, E., Shoenfeld, Y., Sredni, B., Yecheskel, G., Ferrone, S., Zigelman, R., Chaitchik, S., Floro, S., and Djaldetti, M. Vitiligo autoantibodies are effective against melanoma. Cancer (Phila.), 72: 2365-2369, 1993.
3. Bakker, A. B. H., Schreurs, M. W. J., de Boer, A. J., Kawakami, Y., Rosenberg, S. A., Adema, G. J., and Figdor, C. G. Melanocyte lineage-specific antigen gp100 is recognized by melanoma-derived tumor-infiltrating lymphocytes. J. Exp. Med., 179: 1005-1009, 1994.
4. Hoon, D. S. B., Wang, Y., Dale P., Conrad, A. J., Schmid, P., Garrison, D., Kuo, C. K., Foshag, L. J., Nizze, J. A., and Morton, D. L. Detection of occult melanoma cells in melanoma patients blood by polymerase chain reaction assay. J. Clin. Oncol., 13: 2109-2116, 1995.
5. Findler, I. J., and Hart, I. R. Biologic diversity in metastatic neoplasms. Science (Washington DC), 217: 998-1001, 1982.
6. Nowell, P. C. Genetic instability in cancer cells: relationship to tumor cell heterogeneity. In: A. H. Owens, D. S. Coffey, and S. B. Baylin (eds.), Tumor Cell Heterogeneity, pp. 351-365. New York: Academic Press, 1982.
7. Orlow, S. J., Hearing, H. J., Sakai, C., Urabe, K., Zhou, B-K., Silvers, W. K., and Mintz, B. Changes in expression of putative antigens encoded by pigment genes in mouse melanomas at different stages of malignant progression. Proc. Natl. Acad. Sci. USA, 92: 10152-10156, 1995.
8. Winder, A., Kobayashi, T., Katschiko, T., Urabe, K., Aroca, P., Kameyama, K., and Hearing, V. J. The tyrosinase gene family - interactions of melanogenic proteins to regulate melanogenesis. Cell. Mol. Biol. Res., 40: 613-626, 1994.
9. Jimenez-Cervantes, C., Solano, F., Kobayashi, T., Urabe, K., Hearing, V. J., Lozano, J. A., and Garcia-Borron, J. C. A new enzymatic function in the melanogenic pathway. J. Biol. Chem., 269: 17993-18001, 1994.
10. Kwon, B. S., Haq, A. K., Pomerantz, S. H., and Halban, R. Isolation and sequence of a cDNA clone for human tyrosinase that maps at the mouse c-albino locus. Proc. Natl. Acad. Sci. USA, 84: 7473-7477, 1987.
11. Vijayasaradhi, S., Bouchard, B., and Houghton, A. N. The melanoma antigen gp75 is the human homologue of the mouse b (brown) locus gene product. J. Exp. Med., 171: 1375-1380, 1990.
12. Jackson, I. J., Chambers, D. M., Tsukamoto, K., Copeland, N. G., Gilbert, D. J., Jenkins, N. A., and Hearing, V. A second tyrosinase-related protein, TRP-2, maps to and is mutated at the mouse slaty locus. EMBO J., 77: 527-535, 1992.
13. Yokoyama, K., Yasumoto, K., Suzuki, H., and Shibahara, S. Cloning of the human DOPAchrome tautomerase/tyrosinase-related protein 2 gene and identification of two regulatory regions required for its pigment cell-specific expression. J. Biol. Chem., 269: 27080-27087, 1994.
14. Kwon, S. K. Pigmentation genes: the tyrosinase gene family and the Pmel 17 gene family. J. Invest. Dermatol., 700: 134S-140S, 1993.
15. Sensi, M, Traversari, C., Radrizzani, M., Stefania, S., Maccalli, C., Mortarini, R., Rivoltini, L., Faina, C., Nicolini, G., Wolfel, T., Brichard, V., Boon, T., Bordignon, C., Anichini, A., and Parmiani, G. Cytotoxic T-lymphocyte clones from different patients display limited T-cell-receptor variable-region gene usage in HLA-A2-restricted recognition of the melanoma antigen Melan-A/MART-1. Proc. Natl. Acad. Sci. USA, 92: 5674-5678, 1995.
16. Hoon, D. S. B., Banez, M., Okun, E., Morton, D. L., and Irie, R. F. Modulation of human melanoma cells by interleukin-4 and in combination with γ interferon or α-tumor necrosis factor Cancer Res., 57: 2002-2008, 1991.
17. Hayashi, Y., Hoon, D. S. B., Park, M. S., Terasaki, P. I., Foshag, L. J., and Morton, D. L. Generation of HLA-A restricted cytotoxic T cells against melanoma by sensitization with allogeneic melanoma cells bearing shared or cross-reactive HLA-A antigens. Cell Immunol., 739: 411-425, 1992.
18. Doi, F., Chi, D. D. J., Charuworn, B. B., Conrad, A. J., Schmid, P., Morton, D. L., and Hoon, D. S. B. Detection of β-human chorionic gonadotropin mRNA as a marker for cutaneous malignant melanoma. Int. J. Cancer, 65: 454-459, 1996.
19. Hoon, D. S. B., Sarantou, T., Doi, F., Chi, D. D. J., Kuo, C., Conrad, A. J., Turner, R., and Guiliano, A. Detection of metastatic breast cancer by β-hCG polymerase chain reaction. Int. J. Cancer, 69: 369-374, 1996.
20. Conrad, A. J., Schmid, P., Syndulko, K., Singer, E. J., Nagra, R. M., Russel, J. J., and Toutellotte, W. W. Quantifying HIV-1 RNA using the polymerase chain reaction on cerebrospinal fluid and serum of seropositive individuals with and without neurologic abnormalities. J. Acquired Immune Defic. Syndr. Hum. Retrovirology, 10: 425-435, 1995.
21. Hoon, D. S. B., Garrison, D., Chi, D. D. J., Conrad, A. J., Rand, R. W., Morton, D. L., and Merchant, R. E. Molecular detection of tumor-associated antigens shared by human melanomas and gliomas. FASEB J., 10: 1414, 1996.
22. Spruck, C. H., III, Gonzalez-Zulueta, M., and Shibata, A. P16 gene in uncultured tumors. Nature (Lond.), 370: 183-184, 1994.
23. Tsuchida, T., Saxton, R. E., Morton, D. L., and Irie, R. F. Gangliosides of human melanoma. J. Natl. Cancer Inst., 78: 45-54, 1987.
24. Smith, B., Selby, P., Southgate, J., Pittman, K., Bradley, C., and Blair, G. E. Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reaction. Lancet, 338: 1227-1229, 1992.
25. Elder, D. E., Rodeck, U., Thurin, J., Cardillo, F., Clark, W. H., Stewart, R., and Herlyn, M. Antigenic profile of tumor progression stages in human melanocytic nevi and melanomas. Cancer Res., 49: 5091-5096, 1989.
26. Bradl, M., Klein-Szanto, A., Porter, S., and Mintz, B. Malignant melanoma in transgenic mice. Proc. Natl. Acad. Sci. USA, 88: 164-168, 1991.
27. Hoon, D. S. B., and Irie, R. F. Current status of human melanoma vaccines: can they control malignant melanoma? BioDrugs, 1: 66-84, 1997.
28. Maeurer, M. S., Storkus, W. J., Kirkwood, J. M., and Lotze, M. T. New treatment options for patients with melanoma: review of melanoma derived T-cell epitope based on peptide vaccines. Melanoma Res., 6: 11-24, 1996.